Comment on

• Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.

  Hernström V, Josefsson V, Sartor H, Schmidt D, Larsson AM, Hofvind S, Andersson I, Rosso A, Hagberg O, Lång K. Hernström V, et al. Lancet Digit Health. 2025 Mar;7(3):e175-e183. doi: 10.1016/S2589-7500(24)00267-X. Epub 2025 Feb 3. Lancet Digit Health. 2025. PMID: 39904652 Clinical Trial.
• Artificial intelligence-enhanced electrocardiography for the identification of a sex-related cardiovascular risk continuum: a retrospective cohort study.

  Sau A, Sieliwonczyk E, Patlatzoglou K, Pastika L, McGurk KA, Ribeiro AH, Ribeiro ALP, Ho JE, Peters NS, Ware JS, Tayal U, Kramer DB, Waks JW, Ng FS. Sau A, et al. Lancet Digit Health. 2025 Mar;7(3):e184-e194. doi: 10.1016/j.landig.2024.12.003. Lancet Digit Health. 2025. PMID: 40015763